Atlas Venture Fund XII, L.P.

Insider Reports History

Entity
Company
Location
400 Technology Square, 10 Th Floor, Cambridge, MA
Signature
Atlas Venture Fund XII, L.P. By: Atlas Venture Associates XII, L.P., Its: General Partner By: Atlas Venture Associates XII, LLC, Its General Partner, By: /s/ Ommer Chohan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atlas Venture Fund XII, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. 10%+ Owner Common Stock 2.33M $45.4M $19.50 Jul 15, 2022 Direct
Vigil Neuroscience, Inc. 10%+ Owner Common Stock 4.81M $18M $3.75 Jan 11, 2022 By Atlas Venture Fund XII, L.P.
Vigil Neuroscience, Inc. 10%+ Owner Common Stock 1.03M $3.85M $3.75 Jan 11, 2022 By Atlas Venture Opportunity Fund I, L.P.
Vigil Neuroscience, Inc. 10%+ Owner Series A Preferred Stock 0 Jan 11, 2022 By Atlas Venture Fund XII, L.P.
Vigil Neuroscience, Inc. 10%+ Owner Series B Preferred Stock 0 Jan 11, 2022 By Atlas Venture Opportunity Fund I, L.P.

Insider Reports Filed by Atlas Venture Fund XII, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTE Aerovate Therapeutics, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Apr 1, 2022 1 $0 4 Apr 4, 2022 10%+ Owner
VIGL Vigil Neuroscience, Inc. Jan 11, 2022 5 $7.49M 4 Jan 11, 2022 10%+ Owner
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jul 2, 2021 3 $7.5M 4 Jul 6, 2021 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 10%+ Owner